Impact of Calcineurin‐Inhibitor Conversion to mTOR Inhibitor on Renal Allograft Function in a Prednisone‐Free Regimen

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-6143|13|11|2902-2911

ISSN： 1600-6135

Source： AMERICAN JOURNAL OF TRANSPLANTATION, Vol.13, Iss.11, 2013-11, pp. : 2902-2911

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rechallenge with mTOR Inhibitors in Metastatic Renal Cell Carcinoma Patients Who Progressed on Previous mTOR Inhibitor Therapy

By  

Oncology, Vol. 85, Iss. 1, 2013-06 ,pp. : 8-13

Karger

Access to resources Recommend Favorite

Rhinitis in Patients Treated with a Combination of an mTOR Inhibitor and an EGFR Inhibitor

By  

Oncology Research and Treatment, Vol. 33, Iss. 7, 2010-06 ,pp. : 401-402

Karger

Access to resources Recommend Favorite

Mammalian target of rapamycin (mTOR) inhibitor‐associated non‐infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 376-382

John Wiley & Sons Inc

Access to resources Recommend Favorite

Synergistic effects of histone deacetylase inhibitor in combination with mTOR inhibitor in the treatment of prostate carcinoma

By            

International Journal of Molecular Medicine, Vol. 31, Iss. 2, 2013-01 ,pp. : 339-346

Spandidos Publications

Access to resources Recommend Favorite

Predictive factors of allosensitization in renal transplant patients switched from calcineurin to mTOR inhibitors

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 27, Iss. 8, 2014-08 ,pp. : 847-856

John Wiley & Sons Inc

Access to resources Recommend Favorite